Literature DB >> 25785076

Unpredicted effects of Ankaferd® on cartilage tissue.

Cenk Evren1, Mehmet Birol Uğur1, Burhan Yıldırım1, Sibel Bektaş2, Volkan Bilge Yiğit1, Fikret Çınar1.   

Abstract

OBJECTIVE: This study aims to investigate the histopathological changes secondary to the administration of Ankaferd Blood Stopper® (ABS) into the auricular cartilage.
MATERIALS AND METHODS: Both of the auricular cartilages of thirty New Zealand rabbits were marked with tattoo ink. A 0.2-cc ABS (study group, n: 30) and 0.2 cc physiological saline (control group, n: 30) were subcutaneously infused into the right auricle and left auricle, respectively. All layers were removed at 14 days.
RESULTS: The ABS group had significantly higher level of fibrosis, necrosis, foreign body reaction, inflammation, and cartilage degeneration, compared to the controls.
CONCLUSION: Our study results showed that ABS administration into a closed cavity led to a significantly increased fibrosis and necrosis in the auricular cartilage.

Entities:  

Keywords:  Ankaferd; cartilage; hemostatic agent

Year:  2015        PMID: 25785076      PMCID: PMC4358531     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  18 in total

1.  Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper.

Authors:  H Goker; I C Haznedaroglu; S Ercetin; S Kirazli; U Akman; Y Ozturk; H C Firat
Journal:  J Int Med Res       Date:  2008 Jan-Feb       Impact factor: 1.671

Review 2.  Hemostatic drugs.

Authors:  P M Mannucci
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

3.  Effect of ankaferd blood stopper on hemostasis and histopathological score in experimental liver injury.

Authors:  Mustafa Uygar Kalayci; Aliye Soylu; Hasan Erol Eroglu; Dilek Kubilay; Banu Sancak; Ceyhan Ugurluoglu; Ugur Ercin; Yavuz Koca; Oguzhan Karatepe
Journal:  Bratisl Lek Listy       Date:  2010       Impact factor: 1.278

4.  Prospective, randomized, controlled clinical trial of Ankaferd Blood Stopper in patients with acute anterior epistaxis.

Authors:  Aysenur Meric Teker; Arzu Yasemin Korkut; Volkan Kahya; Orhan Gedikli
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-02-13       Impact factor: 2.503

5.  Prospective, controlled clinical trial of Ankaferd Blood Stopper in children undergoing tonsillectomy.

Authors:  Aysenur Meric Teker; Arzu Yasemin Korkut; Orhan Gedikli; Volkan Kahya
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2009-12       Impact factor: 1.675

6.  Tandem oral, rectal, and nasal administrations of Ankaferd Blood Stopper to control profuse bleeding leading to hemodynamic instability.

Authors:  Mevlut Kurt; Erkin Oztas; Sedef Kuran; Ibrahim K Onal; Murat Kekilli; Ibrahim C Haznedaroglu
Journal:  Am J Emerg Med       Date:  2009-06       Impact factor: 2.469

7.  Advanced hemostatic dressing development program: animal model selection criteria and results of a study of nine hemostatic dressings in a model of severe large venous hemorrhage and hepatic injury in Swine.

Authors:  Anthony E Pusateri; Harold E Modrow; Richard A Harris; John B Holcomb; John R Hess; Robert H Mosebar; Thomas J Reid; James H Nelson; Cleon W Goodwin; Glenn M Fitzpatrick; Albert T McManus; David T Zolock; Jill L Sondeen; Rhonda L Cornum; Raul S Martinez
Journal:  J Trauma       Date:  2003-09

8.  The efficacy of Ankaferd Blood Stopper in antithrombotic drug-induced primary and secondary hemostatic abnormalities of a rat-bleeding model.

Authors:  Ali Kosar; Handan S Cipil; Arif Kaya; Burak Uz; Ibrahim C Haznedaroglu; Hakan Goker; Oktay Ozdemir; Sevil Ercetin; Serafettin Kirazli; Huseyin Cahit Firat
Journal:  Blood Coagul Fibrinolysis       Date:  2009-04       Impact factor: 1.276

9.  Hemostatic role of a folkloric medicinal plant extract in a rat partial nephrectomy model: controlled experimental trial.

Authors:  Emre Huri; Turgay Akgül; Ali Ayyildiz; Hüseyin Ustün; Cankon Germiyanoğlu
Journal:  J Urol       Date:  2009-03-19       Impact factor: 7.450

10.  Experimental investigation of the effects of a blood stopper agent (ankaferd blood stopper) on bone surfaces.

Authors:  Hasan Onur Simşek; Mustafa Şenol Tüzüm; Timuçin Baykul; Inanç Elif Gürer; Cumhur İbrahim Başsorgun
Journal:  Turk J Haematol       Date:  2013-06-05       Impact factor: 1.831

View more
  1 in total

Review 1.  Proteomic and transcriptomic analyses to explain the pleiotropic effects of Ankaferd blood stopper.

Authors:  Cem Simsek; Sebnem Selek; Meltem Koca; Ibrahim Celal Haznedaroglu
Journal:  SAGE Open Med       Date:  2017-07-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.